New York Assembly Bill Filed to Allow Marijuana Plant Sales, Senate Companion Already Introduced

A companion bill to Senate Bill 7387 has been filed today in the New York Assembly that would allow licensed marijuana businesses to sell immature cannabis plants directly to consumers for home cultivation.

Assembly Bill 7998 was introduced by Assemblymember Donna Lupardo (D) and has been assigned to the Assembly Committee on Economic Development, Job Creation, Commerce and Industry. The legislation contains the same language as its Senate counterpart, introduced two days ago by Senator Michelle Hinchey (D).

If enacted, the measure would authorize licensed retail dispensaries, microbusinesses, and nurseries to sell up to three immature cannabis plants per person. It defines an immature plant as one “that has not flowered and that does not have visible buds,” and directs the Cannabis Control Board to create regulations for the new sales activity.
Continue reading

Washington State House Approves Cannabis Advertising Bill, Sends It Back to Senate for Concurrence

The Washington State House of Representatives voted 72 to 23 today to approve Senate Bill 5206, legislation that would revise how marijuana retailers can advertise their businesses.

The measure, which previously passed the Senate by a vote of 39 to 9, now returns there for a vote of concurrence due to amendments adopted in the House.

SB 5206 would modify existing rules on marijuana signage and advertising, expanding the number of allowable signs on a retailer’s building from two to four. Signs smaller than 512 square inches would be excluded from this limit.
Continue reading

Largest-Ever Meta-Analysis of Medical Cannabis Finds “Overwhelming Scientific Consensus” for Treating Cancer Symptoms

On Tuesday, April 15, Frontiers in Oncology published the largest meta-analysis ever conducted on medical cannabis and its effects on cancer-related symptoms—a groundbreaking scientific achievement.

Led by Cancer Playbook, powered by Whole Health Oncology Institute (WHOI), this systematic research review aggregated data from over 10,000 peer-reviewed studies—a scale never before achieved in this field, and over ten times the number included in the next-largest review.

Despite the decades-long lack of consensus regarding the efficiency of cannabis in treating cancer symptoms, the meta-analysis showed that for every one study that showed cannabis was ineffective, there were three that showed it worked. That 3:1 ratio—especially in a field as rigorous as biomedical research—isn’t just unusual, it’s extraordinary. The level of consensus found here rivals or exceeds that for many FDA-approved medications.
Continue reading

New Poll Reveals that Most Canadians See Cannabis as a Key Pillar of Canada’s Economic Future, 64% Want Government to Support Industry Growth

Organigram Global Inc., Canada’s #1 cannabis company by market share, today released new public opinion data showing strong national support for growing Canada’s economy through homegrown industries, including the legal cannabis sector.

The national survey, commissioned by Organigram Global and conducted by Abacus Data between April 3–8, 2025, arrives at a pivotal moment for Canada’s economic and political future. With U.S. trade threats escalating under President Donald Trump and federal election day in Canada imminent, Canadians are calling for bold, homegrown strategies that build resilience and secure prosperity. Increasingly, they see the legal cannabis sector as part of the solution.

“Canadians want their country to thrive through innovative, homegrown industries – and cannabis is firmly on that list,” said Beena Goldenberg, CEO of Organigram. “The message from Canadians is clear: Canada’s next Prime Minister must remove barriers and support sectors that deliver jobs, growth, and economic resilience.”
Continue reading

Bipartisan Maine Bill Would Give Licensed Marijuana Cultivators 120-Day Grace Period for Excise Tax Payments

A bill introduced yesterday in the Maine Legislature would give adult-use marijuana cultivation facilities more time to pay excise taxes, easing a key financial burden on growers in the state’s regulated cannabis industry.

House Paper 1095 (LD 1654), sponsored by Representative David Boyer of Poland along with a bipartisan group of 11 other lawmakers, has been referred to both the House and Senate Taxation Committees.

Under current law, licensed cultivation facilities must submit monthly tax returns and pay all excise taxes due from sales made to other cannabis licensees during the prior month. This bill would extend that payment deadline to 120 days after the date of sale.
Continue reading

Delaware Senate Passes Bill to Curb County Restrictions on Marijuana Stores

The Delaware Senate gave approval today to Senate Bill 75, which would limit the ability of counties to restrict marijuana retail and cultivation businesses. The measure now heads to the House for consideration.

SB 75 would prevent counties from prohibiting marijuana retailers from operating in commercial or industrial zones, with exceptions only in specific cases such as proximity to another marijuana business within a half mile or locations like schools, parks, libraries, child care centers, or residential treatment facilities. The bill also requires that counties allow marijuana stores to operate between 9 a.m. and 9 p.m. Monday through Saturday and from noon to 8 p.m. on Sundays.

The Senate approved two amendments before passing the bill. The first, Senate Amendment 1, clarifies that both § 1335A and § 1335B of Title 4 apply when a compassion center receives a conversion license to sell marijuana for both medical and recreational use​.
Continue reading

North Carolina Lawmaker Files “Compassionate Care Act” to Legalize Medical Cannabis

A bill to legalize medical marijuana in North Carolina, titled the Compassionate Care Act, was officially filed today in the North Carolina House of Representatives.

The legislation (House Bill 1011) is sponsored by Representative Aisha Dew and would allow patients with certain debilitating medical conditions to access and use marijuana with a doctor’s recommendation. The bill creates a tightly regulated system overseen by the Department of Health and Human Services and the newly established Medical Cannabis Production Commission.

Under the proposal, individuals with conditions such as cancer, HIV/AIDS, epilepsy, PTSD, Crohn’s disease, sickle cell anemia, Parkinson’s disease, multiple sclerosis, and any condition that leads to hospice care, among others, would be eligible to become medical cannabis patients. Patients would be required to obtain a registry identification card and could designate up to two caregivers to assist them. Those under 18 could only qualify with written consent from a parent or guardian and would be prohibited from smoking or vaping marijuana.
Continue reading

Nevada Assembly Health Committee Approves Bill to Launch Psychedelic Therapy Pilot Program

Today, the Nevada Assembly Health Committee approved a bill that would establish a pilot program for the supervised use of psychedelic substances in mental health treatment.

Nevada State Capitol Building.

Assembly Bill 378 would create the Alternative Therapy Pilot Program, which would allow eligible patients—specifically military veterans and first responders aged 21 and over who have been diagnosed with a mental health condition—to receive psychedelic-assisted therapy at state-approved clinics under medical supervision. The bill identifies psilocybin, psilocin, dimethyltryptamine (DMT), ibogaine, and mescaline as eligible substances for use in the program.

Under the measure, the Nevada Division of Public and Behavioral Health would oversee the program, develop regulations, approve participating patients, clinics, and practitioners, and authorize at least one entity to cultivate or produce the psychedelic substances. The program is intended to operate within the scope of existing federal and state laws while collecting comprehensive data on patient outcomes, safety, and efficacy.
Continue reading

Minnesota Office of Cannabis Management Announces Final Cannabis Rules Published in State Register, Now in Effect

The Minnesota Office of Cannabis Management (OCM) announced yesterday that the rules governing Minnesota’s adult-use cannabis market have been published in the State Register – the final step in making them officially adopted and in effect.

(Photo credit: Getty Images).

The rules were approved by an administrative law judge (ALJ) without changes on April 2. Publishing the rules allows OCM to begin issuing business licenses to applicants who have completed all necessary steps in the application process.

“The adoption of rules is the most significant step to launching the cannabis market because the office cannot issue business licenses until they are in place,” said Interim Director Eric Taubel. “The judge’s approval of our proposed rules without changes shows that we did our work to engage with the prospective cannabis business community and put together a reasonable structure for ensuring consistency, safety, and equity in Minnesota’s cannabis industry.”
Continue reading

Metrc Announces In-Person Events in Illinois to Prepare Cannabis Licensees for Track-and-Trace Transition

Metrc, the most trusted and experienced provider of cannabis regulatory technology systems in the U.S., announced it will host in-person roadshows throughout Illinois to help licensed businesses prepare for the state’s transition to Metrc as the track-and-trace system of record.

The Illinois events will include important information to help licensees get up and running quickly while making the most of Metrc, ensuring a smooth and complete market transition by the end of June 2025. Sessions will cover how to gain access to the system and set up your business, as well as best practices for operational success. There will also be a live Q&A to address questions from attendees. Metrc will host the following sessions for all license types. Illinois licensees can secure tickets, free of charge, at the links below.
Continue reading